Enclave Advisors »

Regeneron Pharmaceuticals shares owned by Enclave Advisors

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Enclave Advisors from 13F filings

Historical chart of Enclave Advisors investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Enclave Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Enclave Advisors

Quarter filed Position value Share count Share price at filing
2025-06-30 $240k 457 525.54
2025-03-31 $310k 488 634.52
2024-12-31 $279k 392 712.33
2024-09-30 $313k 298 1051.24